Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
GLP-1 medications could have far-reaching implications for a wide variety of conditions, from liver disease to sleep apnea to heart
Read MoreGLP-1 medications could have far-reaching implications for a wide variety of conditions, from liver disease to sleep apnea to heart
Read MoreStructure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic and weight loss
Read MorePublic health officials are urging eligible Americans to take all three shots so the nation can avoid another "tripledemic" of
Read MoreEG.5 or "Eris," now the dominant variant in the United States, is currently thought to have the same risk level
Read MoreIt's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their
Read MorePfizer's Rocky Mount facility supplies 8% of all sterile injectable medicines used in U.S. hospitals, including anesthesia, analgesia and anti-infectives.
Read MoreDespite missing Wall Street's revenue expectations, shares of Uber rose more than 4% after the ride-hailing giant offered rosy guidance
Read MoreThere is no proven treatment for long Covid-19, which can cause a range of debilitating symptoms in millions of Americans.
Read MoreWhen all is said and done, about 160 S&P 500 companies will have reported their latest quarterly results this week
Read More